Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Foster
FSTR
$438M
| $196K | ﹤0.01% |
15,373
+2,241
| +17% | +$28.8K |
|
4027
US Global Jets ETF
JETS
$803M
| $196K | ﹤0.01% |
+11,785
| New | +$179K |
|
4028
CALL
Assured Guaranty
AGO
$3.66B
| $195K | ﹤0.01% |
8,000
-9,700
| -55% | -$264K |
|
4029
CALL
Prudential Financial
PRU
$41.9B
| $195K | ﹤0.01% |
3,200
-52,000
| -94% | -$3.05M |
|
|
ALBO
4030
DELISTED
Albireo Pharma Inc
ALBO
| $195K | ﹤0.01% |
7,316
+3,150
| +76% | +$74.3K |
|
4031
BrightView Holdings
BV
$1.02B
| $194K | ﹤0.01% |
17,270
+6,762
| +64% | +$81.9K |
|
4032
InfuSystem Holdings
INFU
$236M
| $194K | ﹤0.01% |
+16,855
| New | +$194K |
|
4033
Ooma
OOMA
$588M
| $194K | ﹤0.01% |
11,780
+4,993
| +74% | +$62.5K |
|
|
SGMO
4034
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $194K | ﹤0.01% |
21,700
-33,800
| -61% | -$314K |
|
4035
PUT
Cheniere Energy
LNG
$55.7B
| $193K | ﹤0.01% |
4,000
-57,200
| -93% | -$2.5M |
|
|
BRT
4036
BRT Apartments
BRT
$271M
| $192K | ﹤0.01% |
17,716
+2,298
| +15% | +$23.4K |
|
4037
Daily Journal
DJCO
$795M
| $192K | ﹤0.01% |
712
+248
| +53% | +$65.9K |
|
|
ROCC
4038
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $192K | ﹤0.01% |
+20,193
| New | +$156K |
|
|
OTRK
4039
DELISTED
Ontrak
OTRK
| $191K | ﹤0.01% |
86
+60
| +231% | +$120K |
|
|
ORBC
4040
DELISTED
ORBCOMM, Inc.
ORBC
| $191K | ﹤0.01% |
49,486
+25,183
| +104% | +$75.2K |
|
4041
Bar Harbor Bankshares
BHB
$673M
| $190K | ﹤0.01% |
8,479
+3,428
| +68% | +$63.9K |
|
4042
Modine Manufacturing
MOD
$10.2B
| $190K | ﹤0.01% |
34,638
+12,016
| +53% | +$55.2K |
|
4043
Peapack-Gladstone Financial
PGC
$815M
| $190K | ﹤0.01% |
10,182
+4,018
| +65% | +$71.2K |
|
4044
CALL
Pentair
PNR
$11.2B
| $190K | ﹤0.01% |
5,000
-3,100
| -38% | -$109K |
|
4045
Waterstone Financial
WSBF
$375M
| $190K | ﹤0.01% |
12,921
+5,055
| +64% | +$71.6K |
|
4046
PUT
Yelp
YELP
$1.38B
| $190K | ﹤0.01% |
8,200
-10,300
| -56% | -$224K |
|
|
ITIC
4047
Investors Title Co
ITIC
$558M
| $189K | ﹤0.01% |
1,552
+1,088
| +234% | +$136K |
|
4048
NatWest
NWG
$75.8B
| $189K | ﹤0.01% |
57,417
-20,656
| -26% | -$64.2K |
|
4049
Stantec
STN
$8.34B
| $189K | ﹤0.01% |
6,100
| – | – |
|
4050
Expro Ltd
XPRO
$1.91B
| $189K | ﹤0.01% |
14,209
+8,317
| +141% | +$112K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.